Carey OConnor Kolaja
CIK 1848717 · last filed 2025-02-06
Carey OConnor Kolaja is a corporate insider who has filed 8 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for RVNC, was dated Feb 6, 2025. Across all open-market trades the lifetime net is −$70.6K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
8
-$70.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 0 | $3.65 | $0 | -$70.6K | 8 | 2025-02-06 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Mixed | −31,561 | -$60.4K | EDGAR |
| 2024-05-03 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2023-06-20 | Revance Therapeutics, Inc. (RVNC) Delisted | Mixed | — | -$25.3K | EDGAR |
| 2023-05-05 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +3,534 | $0 | EDGAR |
| 2022-05-13 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,059 | $0 | EDGAR |
| 2021-05-07 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +674 | $0 | EDGAR |
| 2021-03-02 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,294 | $0 | EDGAR |